Journey Medical DERM
NASDAQ DERM
$7.34 +0.53 (+7.78%)
At close: Aug 20, 2026 · 11:48 AM UTC

Journey Medical (DERM) Finished Goods (2020 - 2021)

Journey Medical's (DERM) quarterly Finished Goods came in at $4.3 million in Q4 2021, up 205.56% YoY from $1.4 million in Q4 2020, and down 30.37% on a QoQ basis from $6.2 million in Q3 2021.

Journey Medical (DERM) Finished Goods (2020 - 2021) Analysis & Trends

Journey Medical (DERM) has 2 years of Finished Goods data on file, last reported at $4.3 million in Q4 2021.

  • Quarterly Finished Goods rose 205.56% year-over-year to $4.3 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $4.3 million (up 205.56% YoY) and the FY2021 annual result came in at $4.3 million, up 205.56% from the prior year.
  • Finished Goods fell to $4.3 million in Q4 2021, from $6.2 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $6.2 million in Q3 2021 to a low of $1.4 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.07 Bn 43.10 Bn -
2 Teva Pharmaceutical Industries 43.42 Bn 39.76 Bn 2.15 Bn
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.77 Bn 22.98 Bn 5.10 Bn
5 United Therapeutics 22.29 Bn 19.63 Bn 683.80 Mn
6 Viatris 18.78 Bn 17.89 Bn 1.46 Bn
7 Neurocrine Biosciences 15.66 Bn 15.27 Bn 935.80 Mn
8 Elanco Animal Health 11.91 Bn 11.38 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn -
10 Journey Medical 201.80 Mn 176.16 Mn 12.37 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 4.29 Mn
Sep 30, 2021 6.16 Mn
Dec 31, 2020 1.40 Mn